Adial Pharmaceuticals, Inc (ADIL) analyst actions
Rating and price-target actions on ADIL in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ADIL overview →
1 measured ADIL analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study | Press release | -0.03% | -1.05% |
Keep exploring
More ADIL: earnings → · SEC filings → · ADIL overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Vivakor, Inc. (VIVK) | 243 | -0.30% | 36% |
| IKANG HEALTH CARE GROUP (KANG) | 242 | -0.07% | 44% |
| Dare Bioscience, Inc. (DARE) | 241 | 0.00% | 43% |
| Genprex, Inc. (GNPX) | 241 | -1.17% | 33% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.